Company Overview - Elevance Health (NYSE: ELV) is a major health insurance provider in the United States, serving approximately 47 million members [1] - The company appears to be in strong financial condition [1] Stock Performance - Elevance Health's stock has significantly outperformed the overall market [1] Author Background - The author holds a Ph.D. in engineering and has expertise in acoustics and noise research [2] - The author is passionate about finance and stock investment, with a focus on capital appreciation opportunities [2] - The author's investment strategy includes purchasing high-quality undervalued companies and reasonably priced growth companies [2] - The author also invests in dividend-paying stocks that are good companies and correctly priced [2] Note: The content does not provide specific financial data, percentage changes, or detailed industry analysis, so those aspects are not included in the summary

U.S. health benefits company Elevance Health, Inc. (ELV) shares have declined 29.6% quarter to date, underperforming its industry and the S&P 500 Index. Closing at $366.48 on Thursday, near its 52-week low of $362.21, the company’s current share price seems an excellent opportunity to build a position in a renowned company. After all, you would much rather buy closer to the low than the high, right?Elevance Health, headquartered in Indianapolis, IN, has a market capitalization of $84.9 billion. Its peers, U ...

SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors violated securities laws and breached fiduciary duties to shareholders. Elevance is a healthcare company that supports consumers, families, and communities across the entire care journey. What Now: If you own shares of Elevance Health Inc. and have lost money in your investment, contact us for more information ab ...

Elevance Health (NYSE: ELV ) is one of the largest healthcare insurers in the US. During FY23, they had 45 million members and had served over 115 million people. They have enjoyed revenue growth of 9.1% over the past 10 years and 13.7% EPSWe use Cash Flow Returns On Investment based DCF valuation tools provided by our affiliate company, ROCGA Research.With over 20 years of experience in investment analysis, we are actively seeking out undervalued and quality companies.ROCGA Research is an online platform t ...

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securities laws by misrepresenting or failing to timely disclose material information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Elevance securities? If you purchased securities and suffered losses on your investmen ...

Elevance Health, Inc. (NYSE:ELV) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J. Rice I think we'll go ahead and kick off today. I'm A.J. Rice, the health care services analyst at UBS. Thanks, everybody, for coming out to our conference this year. We're very pleased to have to kick off our session Elevance Health and principal speaker is going to be Mark Kaye, Chief Financial Officer and Exec ...

Elevance Health, Inc.'s (ELV) shares have lost 20% in the past three months compared with the industry's 7.1% decline. It has also lagged the broader Zacks Medical sector's 3.7% decline and the S&P 500's 10.4% rise in the said time frame. It has a market cap of $95.8 billion. Closing at $425.39 in the last trading session, the stock of the health benefit company stands 25% below its 52- week high of $567.26. Image Source: Zacks Investment Research What's Weighing on Elevance Health's Performance? Elevance H ...

SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Elevance securities? If you purchased securities and suffered losse ...

GERMANY - 2024/02/15: In this photo illustration, Elevance Health, Inc. logo seen displayed on a ... [+] tablet. (Photo Illustration by Igor Golovnov/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesElevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnings of $8.37 per share, compared to the street estimates of $43.5 billion and $9.66, ...

Analyst's Disclosure: I/we have a beneficial long position in the shares of ELV, CI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. The contents of this article, my previous articles, and my comments are for informational purposes only and may not be considered investmen ...